恶梦
发表于 2025-3-21 18:14:58
书目名称Bisphosphonates in Clinical Oncology影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0188891<br><br> <br><br>书目名称Bisphosphonates in Clinical Oncology读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0188891<br><br> <br><br>
条约
发表于 2025-3-21 23:20:24
Pamidronate,onate might be affected by the rate of administration, a prospective pharmacokinetic study of pamidronate at three different infusion rates was started in the Department of Internal Medicine C, Kantonsspital St. Gallen KSSG, Switzerland and in the Centre Pluridisciplinaire d’Oncologie and the Depart
EPT
发表于 2025-3-22 00:47:35
http://reply.papertrans.cn/19/1889/188891/188891_3.png
consent
发表于 2025-3-22 05:12:35
http://reply.papertrans.cn/19/1889/188891/188891_4.png
乏味
发表于 2025-3-22 11:43:19
http://reply.papertrans.cn/19/1889/188891/188891_5.png
障碍
发表于 2025-3-22 15:46:37
Torsionsschwingungen in Antriebssystemen,nt. Finally, a prospective, randomized, double-blind, placebo-controlled, three-arm, phase-III study of ibandronate has been conducted in patients with breast cancer and bone metastases (SG 143/94). No results are available to the public so far.
projectile
发表于 2025-3-22 17:49:06
http://reply.papertrans.cn/19/1889/188891/188891_7.png
GUISE
发表于 2025-3-22 21:17:30
Pamidronate,ew medication and no chemotherapy was started for at least 72 hr prior to entry or at any time during the study. Median creatinine clearance was 66 ml/min (range 37–110 ml/min). Mean age was 63 years (range 28–78 years). Thirty-two of the 37 patients suffered from bone metastases of breast cancer. T
带来墨水
发表于 2025-3-23 05:08:37
http://reply.papertrans.cn/19/1889/188891/188891_9.png
商品
发表于 2025-3-23 09:20:20
Beat ThürlimannImportant pathophysiological background of bone complications.Treatment possibilities